Unanticipated improvement in seizure control in drug-resistant epilepsy-real world observations

被引:5
|
作者
Moloney, Patrick B. [1 ]
Costello, Daniel J. [1 ,2 ]
机构
[1] Cork Univ Hosp, Dept Neurol, Cork, Ireland
[2] Univ Coll Cork, Coll Med & Hlth, Cork, Ireland
来源
关键词
Drug-resistant epilepsy; Anti-seizure medication; Unanticipated treatment response; Rational polytherapy; QUALITY-OF-LIFE; ANTIEPILEPTIC DRUGS; ILAE COMMISSION; REMISSION; POPULATION; LACOSAMIDE; OUTCOMES; SURGERY; RELAPSE;
D O I
10.1016/j.seizure.2020.11.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To determine the clinical features and anti-seizure medication (ASM) strategies associated with an unanticipated substantial improvement in seizure control in patients with drug-resistant epilepsy (DRE). Methods: This retrospective analysis of patients attending a tertiary care epilepsy clinic between 2008 and 2017 identified all patients with active DRE (at least 1 seizure per month for 6 months, despite treatment with 2 different ASMs). All treatment interventions were recorded from when DRE was first identified to the end of the study. The primary end points were seizure freedom or meaningful reduction in seizure frequency (greater than 75 %) sustained for at least 12 months after a treatment intervention. Results: Three hundred and twenty-two patients were included in the analysis. Overall, 10 % became seizure free following ASM adjustment and an additional 10 % had a greater than 75 % improvement in seizure control (median follow-up, 4 years). An ASM introduction was ten times more likely than an ASM dose increase to improve seizure control. Combined focal and generalized epilepsy, intellectual disability and prior treatment with more than 5 ASMs were more frequently observed in those with continued pharmacoresistance. ASM responders were more likely to have primary generalized epilepsy. Rational polytherapy (combining ASMs with different mechanisms of action) was almost ubiquitous amongst ASMs responders (95 % taking at least 2 drugs with different mechanistic targets). Of the ASM additions that heralded improved seizure control, 85 % were maintained at submaximal doses. Conclusions: This retrospective analysis of a large number of 'real-world' patients provides evidence to persist with ASM trials in DRE. Early rotation of ASMs if a clinical response is not observed at a substantial dose and rational ASM polytherapy may yield better clinical outcomes in patients with DRE, although a prospective study would need to be conducted to validate these findings.
引用
收藏
页码:60 / 65
页数:6
相关论文
共 50 条
  • [1] Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations
    Vecht, Charles
    Duran-Pena, Alberto
    Houillier, Caroline
    Durand, Thomas
    Capelle, Laurent
    Huberfeld, Gilles
    JOURNAL OF NEURO-ONCOLOGY, 2017, 133 (03) : 603 - 607
  • [2] Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations
    Charles Vecht
    Alberto Duran-Peña
    Caroline Houillier
    Thomas Durand
    Laurent Capelle
    Gilles Huberfeld
    Journal of Neuro-Oncology, 2017, 133 : 603 - 607
  • [3] Deep brain stimulation for seizure control in drug-resistant epilepsy
    Klinger, Neil
    Mittel, Sandeep
    NEUROSURGICAL FOCUS, 2018, 45 (02)
  • [4] Seizure clusters in drug-resistant focal epilepsy
    Asadi-Pooya, Ali A.
    Nei, Maromi
    Sharan, Ashwini
    Sperling, Michael R.
    EPILEPSIA, 2016, 57 (09) : E187 - E190
  • [5] SEIZURE FREEDOM IN DRUG-RESISTANT EPILEPSY (DRE)
    Kwan, Patrick
    EPILEPSIA, 2023, 64 : 1 - 1
  • [6] Quickest Seizure Onset Detection in Drug-Resistant Epilepsy
    Santaniello, Sabato
    Burns, Samuel P.
    Sarma, Sridevi V.
    2012 AMERICAN CONTROL CONFERENCE (ACC), 2012, : 4771 - 4776
  • [7] Seizure response to perampanel in drug-resistant epilepsy with gliomas
    Pena, A. Duran
    Houillier, C.
    Durand, T.
    Capelle, L.
    Huberfeld, G.
    Vecht, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 665 - 665
  • [8] Seizure outcome in drug-resistant epilepsy in the setting of polymicrogyria
    Aung, Thandar
    Bo, Jin
    Bingaman, William
    Najm, Imad
    Alexopoulos, Andreas
    Bulacio, Juan C.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2024, 121 : 226 - 234
  • [9] Impact of epilepsy duration, seizure control and EEG abnormalities on cognitive impairment in drug-resistant epilepsy patients
    Aleksandar Gavrilovic
    Gordana Toncev
    Tatjana Boskovic Matic
    Katarina Vesic
    Jelena Ilic Zivojinovic
    Jagoda Gavrilovic
    Acta Neurologica Belgica, 2019, 119 : 403 - 410
  • [10] Impact of epilepsy duration, seizure control and EEG abnormalities on cognitive impairment in drug-resistant epilepsy patients
    Gavrilovic, Aleksandar
    Toncev, Gordana
    Matic, Tatjana Boskovic
    Vesic, Katarina
    Zivojinovic, Jelena Ilic
    Gavrilovic, Jagoda
    ACTA NEUROLOGICA BELGICA, 2019, 119 (03) : 403 - 410